SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Verano Holdings Corp. (VRNO)

United States · Delayed Price · Currency is USD
5.27-0.02 (-0.38%)
 
Market Cap385.86M-36.1%
Revenue (ttm)835.52M
Net Income-258.48M
EPS-3.53
Shares Out73.22M
PE Ration/a
Forward PE9.88
Dividendn/a
Ex-Dividend Daten/a
Volume18,997
Open5.33
Previous Close5.29
Day's Range5.26 - 5.41
52-Week Range3.91 - 9.75
Beta1.48
Analystsnone
Price Target25.00(+374.38%)
Earnings DateOct 29, 2026
-0.38% (1D)
No price history available.
Insider Score
––Not scored
VRNO Insider Score

Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About VRNO

Verano Holdings Corp. engages in the cannabis business in the United States. It is involved in the cultivation, processing, wholesale, and retail distribution of cannabis. The company also designs, builds, and operates cannabis dispensaries. It sells its products under the Encore, Avexia, MÜV, Savvy, Essence, BITS, HYPHEN, Swift Lifts, Verano, and Zen Leaf brand names to medical and adult use markets. The company is headquartered in Chicago, Illinois.

Address
224 West Hill Street, Chicago, IL, 60610, United States
Market Cap
386 million
Employees
3,800
Industrial Classification
Drug Manufacturers - Specialty & Generic
1 Day
-0.38%
5 Days
-1.31%
1 Month
-12.89%
6 Months
-12.17%
1 Year
-36.12%

$VRNO stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in VRNO holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by VRNO's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

VRNO Estimated quarterly lobbying spending

Source: U.S. Senate LDA

VRNO Revenue by Segment

$531.12MTotal
SegmentRevenue% of All
Revenues, net of Discounts$217.92M41.03%
Retail$182.16M34.30%
Wholesale$79.81M15.03%
Adjusted EBITDA$51.23M9.65%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New VRNO patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to VRNO from public contracts

Source: USAspending.gov

VRNO Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for VRNO yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from VRNO’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.